Results

Total Results: 1,562 records

Showing results for "defined".

  1. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/thromboembolism-update_research-protocol.pdf
    February 17, 2016 - Treatment adherence/compliance Interventions •   Pharmacologic VTE prophylaxis agents within the defined … vitamin K antagonists KQ 1, 4 (in combination), 5, 6 •   Mechanical VTE prophylaxis devices within the defined … leading to readmission §   Surgical site / joint bleeding §   Bleeding leading to infection §   As defined … Symptomatic   o Proximal     § Treatment  adherence   Adverse  events   § Major  bleeding   o As  defined
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-tests-proposals_research.pdf
    January 01, 2009 - controlled clinical studies intended to provide a reasonable assurance of safety and effectiveness in defined … sufficient in providing evidence of improvement or equivalence in patient outcomes if there is a well-defined … there is not always a reference standard available, nor is it clear how the target condition should be defined … subset of those tested, so sample size requirements can be substantial.45 Trials of testing need a well-defined
  3. effectivehealthcare.ahrq.gov/sites/default/files/whitepaper3-lijmer02262010-2.pdf
    January 01, 2009 - controlled clinical studies intended to provide a reasonable assurance of safety and effectiveness in defined … sufficient in providing evidence of improvement or equivalence in patient outcomes if there is a well-defined … there is not always a reference standard available, nor is it clear how the target condition should be defined … subset of those tested, so sample size requirements can be substantial.45 Trials of testing need a well-defined
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-d.xlsx
    January 01, 2023 - introduce some bias for outcome assessment ITACA-S OS Low Low Low Low Low Low open label, but had pre-defined … concerns regarding blinding ITACA-S Grade 3 to 5 AEs Low Low Low Low Low Low open label, but had pre-defined
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
    January 15, 2016 - TEP reviewer #5 General The target population is explicitly defined. … define an underlying latent response distribution (like typically seen in a probit model), with πjk defined … We also provide the probability of each treatment being the best, where "best" is defined as having … We have defined this--"long" is in relation to a shorter pulse duration in the comparison group. … reviewer #4 Results Figure 5, as implied in the discussion above, it is not clear how clearance was defined
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-topic-refinement.pdf
    November 01, 2022 - Where needed, we used the following definitions for real-world data and real-world evidence as defined … In the protocol, the sponsors/investigators describe plans for analyzing demographic subpopulations, defined … studies may meet this requirement only if the disease or condition being studied is life threatening as defined … studies may meet this requirement only if the disease or condition being studied is life threatening as defined … In the protocol, the sponsors/investigators describe plans for analyzing demographic subpopulations, defined
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_executive.pdf
    September 19, 2014 - Introduction Background Chronic pain, often defined as pain lasting longer than 3 months or past the … We selected studies of adults (age >18 years) with chronic pain (defined as pain lasting >3 months) … We defined long-term opioid therapy as use of opioids on most days for >3 months; this threshold was … instruments based on whether it evaluated a consecutive or random sample of patients meeting pre- defined … We were also unable to determine how benefits and harms vary in subgroups, such as those defined by
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-surveillance_research-protocol.pdf
    May 19, 2011 - A well-defined clinical benefit of immediate therapy with curative intent has not been demonstrated … geographical access Question 2 How are active surveillance and other observational strategies defined
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
    June 12, 2013 - Background and Objectives for the Systematic Review Menopause is defined as the permanent cessation … the period from the last menses to death as postmenopause;1-3 the first 5 postmenopausal years are defined … Question 4 Does effectiveness and adverse effects vary among subgroups of patients defined by … Data will be abstracted into tables created in DistillerSR, with elements defined by an accompanying … follow-up in each arm • Measurements equal, reliable, and valid • Interventions comparable and clearly defined
  10. effectivehealthcare.ahrq.gov/sites/default/files/technical-brief-34-health-worker-certification-summary.pdf
    March 01, 2020 - American Public Health Association Community Health Worker Section, a community health worker is defined
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
    October 01, 2010 - rFVIIa in Premier database, 2000-2008* * The unit of analysis was any hospital “case” of rFVIIa use—defined
  12. effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
    January 01, 2005 - inclusion: Describes an information tool for use by consumers/patients Addresses treatment of a defined
  13. Dia 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/ijzerman_ahrq-webinar-mcda.pdf
    January 01, 2011 - We have defined 3 criteria (Ci) and 3 levels (Li)  Cooking style Italian, Greek or Thai  Travel
  14. effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-antenatal-care.pdf
    April 01, 2021 - visit, or instead of a “routine visit”) Comparators Standard or routine antenatal care program (as defined … Also consider service provider) Standard or routine antenatal care program (as defined by the study … Furthermore, the various uses of telehealth in antenatal care could be defined in a systematic review
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
    January 01, 2009 - Applicability is defined as the extent to which the results observed in published studies are likely … Defining Applicability Defining Applicability Applicability is defined as the extent to which the … improper definitions for outcomes, composite endpoints Outcomes (benefits and harms) and how they were defined … For outcomes, the researcher needs to evaluate the outcomes and how they were defined.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
    April 20, 2015 - small but significant risk of bleeding and tumor seeding – limiting its widespread use and a well-defined … Patients with surgical chronic kidney disease (defined as chronic kidney disease as a result of surgical … strategies differ according to a patient’s demographic or clinical characteristics, or disease severity defined … Risk of bias judgment Bias in measurement of interventions 3.1 Is intervention status well defined … Definition of Terms Local recurrence - Local recurrence is defined as any persistent or recurrent
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
    March 01, 2010 - ): Within African-American, Hispanic, or White racial/ethnic groups; and • H0(3): Within subgroups defined … Statistical Analysis We compared baseline characteristics across subgroups defined by H-ISDN exposure … No mortality hazard ratios were significantly <1.0 in the 15 subgroups defined by racial/ethnic status
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_executive.pdf
    November 01, 2012 - Although we abstracted data for severe fibrosis (defined as biopsy showing METAVIR F3-F4, Ishak 4-6 … , or equivalent), we summarized results for fibrosis (defined as biopsy showing METAVIR F2-F4, Ishak … 3-6, or equivalent) and cirrhosis (defined as biopsy showing METAVIR F4, Ishak 5-6, or equivalent … Diagnostic accuracy: Platelet counts vs. liver biopsy Low For fibrosis (defined as METAVIR F2-F4, Ishak … For cirrhosis (defined as METAVIR F4, Ishak 5-6, or equivalent), the AUROC was 0.89 (range 0.64 to
  19. effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - EPC Investigator Other Experts Conclusion from SCEPC Treatment failure at 5 years of follow-up, defined … addition of neoadjuvant hormonal therapy to RP did not improve survival or cancer recurrence rates, defined … There was a trend toward more radiation proctitis, defined aspersistent bleeding, with 125I. … Treatment failure at 5 years of follow-up, defined as acid phosphatase elevation on two consecutive … There was a trend toward more radiation proctitis, defined as persistent bleeding, with 125I.
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - EPC Investigator Other Experts Conclusion from SCEPC Treatment failure at 5 years of follow-up, defined … addition of neoadjuvant hormonal therapy to RP did not improve survival or cancer recurrence rates, defined … There was a trend toward more radiation proctitis, defined aspersistent bleeding, with 125I. … Treatment failure at 5 years of follow-up, defined as acid phosphatase elevation on two consecutive … There was a trend toward more radiation proctitis, defined as persistent bleeding, with 125I.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: